FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 14, 2024 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Heart Test Laboratories, Inc. (Exact name of Registrant as Specified in Its Charter) Texas 001-41422 26-1344466 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 550 Reserve Street, Suite 360 Southlake, Texas 76092 (Address ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 HEART TEST LABORATORIES, INC. (Exact Name of Registrant as Specified in its Charter) | TEXAS | 26-1344466 | | --- | --- | | ( State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | | 550 Reserve Street, Suite 360 | | | Southlake, Texas | 76092 | | (Address of principal executive off ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 31, 2023 Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," an ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-41422 HEART TEST LABORATORIES, INC. (Exact Name of Registrant as Specified in its Charter) | TEXAS | 26-1344466 | | --- | --- | | ( State or other jurisdiction of | ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended April 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-41422 HEART TEST LABORATORIES, INC. (Exact name of Registrant as specified in its Charter) TEXAS 26-1344466 (State or ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-41422 HEART TEST LABORATORIES, INC. (Exact Name of Registrant as Specified in its Charter) | TEXAS | 26-1344466 | | --- | --- | | ( State or other jurisdiction o ...

Heart Test Laboratories, Inc. Nasdaq: HSCS MyoVista® Wavelet ECG Game Changing AI Technology for the Early Detection of Heart Disease. Not FDA Cleared or Approved AI + Advanced Signal Processing - Designed to Revolutionize ECG for Heart Screening October 26, 2022 AI and Wavelet Signal Processing INVESTOR OVERVIEW SAFE HARBOR Certain data in this presentation was obtained from various external sources, and neither "HeartSciences" or the "Company" nor its affiliates or representatives has verified such data w ...